A major immunodeficiency whose rarity means it may well stay undiagnosed or misdiagnosed in a affected person for years now has its first drug. The FDA has authorised a once-daily remedy that addresses the underlying genetic downside that causes the inherited situation generally known as WHIM syndrome. The regulatory resolution introduced Monday for the drug X4 Prescription drugs covers WHIM […]